svpn news
forbes.com ↗
Despite a nearly 600% surge in adolescent GLP-1 prescriptions, the WHO says they may pose critical safety risks to growing bodies.
Log in or sign up to comment.
No comments yet.
← Back to stories
Log in or sign up to comment.